Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies

This publication has 14 references indexed in Scilit:

• Radioimmunoassay of Zidovudine
  Therapeutic Drug Monitoring, 1997
• Phase I Study of Atevirdine, a Nonnucleoside Reverse Transcriptase Inhibitor, in Combination with Zidovudine for Human Immunodeficiency Virus Type 1 Infection
  The Journal of Infectious Diseases, 1995
• Evaluation of effects of altered gastric pH on absorption of dapsone in healthy volunteers
  Antimicrobial Agents and Chemotherapy, 1994
• Inhibition of Human Immunodeficiency Virus Type 1 Replication In Vitro by the Bisheteroarylpiperzine Atevirdine (U-87201E) in Combination with Zidovudine or Didanosine
  The Journal of Infectious Diseases, 1993
• U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication
  Antimicrobial Agents and Chemotherapy, 1993
• Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication.
  Proceedings of the National Academy of Sciences, 1991
• Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
  Proceedings of the National Academy of Sciences, 1991
• Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor
  Science, 1990
• Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
  Nature, 1990
• Gastric Secretory Failure in Patients with the Acquired Immunodeficiency Syndrome (AIDS)
  Annals of Internal Medicine, 1988